Stay updated on UBX1325 Safety in Macular Disease Clinical Trial
Sign up to get notified when there's something new on the UBX1325 Safety in Macular Disease Clinical Trial page.

Latest updates to the UBX1325 Safety in Macular Disease Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 replaces v3.4.1 on the page. No study content or critical sections appear to be changed; to avoid alerting for small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedUI revision from v3.4.0 to v3.4.1 was applied and does not modify any study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedShow glossary toggle was added and several metadata labels were updated: 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and Revision to v3.4.0, replacing the previous 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and Revision: v3.3.4.SummaryDifference0.2%

- Check42 days agoChange DetectedThe site template updated from v3.3.3 to v3.3.4; no study details or user-facing content were changed.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a dedicated Locations section listing California, Florida, Indiana, and Texas as study sites, and removed the individual state location sections for these states. Updated the page revision from v3.3.2 to v3.3.3 and removed the HHS Vulnerability Disclosure footer link.SummaryDifference0.6%

- Check92 days agoChange DetectedThe Publications note is updated to say PubMed publications are automatically filled and may not pertain to the study, replacing the former description. A Revision: v3.3.2 label is added.SummaryDifference0.1%

Stay in the know with updates to UBX1325 Safety in Macular Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the UBX1325 Safety in Macular Disease Clinical Trial page.